Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect
Enrico Maffini, Larry D. Anderson, Brenda M. Sandmaier, Damian J. Green, Barry E. Storer, Dietger Niederwieser, Richard T. Maziarz, David G. Maloney, Rainer Storb
Haematologica March 2018 : haematol.2017.184176; doi:10.3324/haematol.2017.184176

Author Affiliations

  1. Enrico Maffini1,
  2. Larry D. Anderson Jr.2,
  3. Brenda M. Sandmaier3,
  4. Damian J. Green3,
  5. Barry E. Storer3,
  6. Dietger Niederwieser4,
  7. Richard T. Maziarz5,
  8. David G. Maloney3 and
  9. Rainer Storb6,*
  1. 1 Fred Hutchinson Cancer Research Center;
  2. 2 University of Texas Southwestern (UT Southwestern) Medical Center;
  3. 3 Fred Hutchinson Cancer Research Center and the University of Washington;
  4. 4 University Hospital of Leipzig, Leipzig, Germany;
  5. 5 Oregon Health & Science University;
  6. 6 Fred Hutchnison Cancer Center and the University of Washington School of Medicine
  1. ↵* Corresponding author; email: rstorb{at}fredhutch.org

Abstract

-

  • Received November 7, 2017.
  • Accepted February 7, 2018.
Back to top

Keywords

Indolent Non-Hodgkin's Lymphoma
Lymphoproliferative Disorders
stem cell transplantation
Email
Citation Tools

Jump To

What about you?
Tell us your interests and get all the new contents of Haematologica in advance